SCHEMBL18680906

SCHEMBL18680906

Cc1ccc(F)c(SCl)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.40
ALOX15 P16050 3/20 0.40
MEN1 O00255 2/20 0.40
LMNA P02545 2/20 0.40
KMT2A Q03164 2/20 0.40
HSD17B10 Q99714 2/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
ALOX12 P18054 1/20 0.40
NFE2L2 Q16236 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
ACHE P22303 4/20 0.35
CYP2A6 P11509 3/20 0.35
CYP1A2 P05177 2/20 0.35
TDP1 Q9NUW8 5/20 0.34
NISCH Q9Y2I1 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23912730 0.82 NFE2L2 (0.36) TP53ALOX15MEN1LMNAKMT2A
SCHEMBL22564795 0.81 ALOX15 (0.43) TP53ALOX15MEN1LMNAKMT2A
SCHEMBL11822275 0.78 TP53 (0.44) TP53ALOX15MEN1LMNAKMT2A
SCHEMBL20311493 0.77 ALOX15 (0.41) TP53ALOX15MEN1LMNAKMT2A
SCHEMBL2019539 0.76 HSD17B10 (0.43) TP53ALOX15MEN1LMNAKMT2A
SCHEMBL18680666 0.76 CA3 (0.42) NFE2L2CYP2A6CYP1A2TDP1ALDH1A1
SCHEMBL18680742 0.76 CYP3A4 (0.43) TP53ALOX15MEN1LMNAKMT2A
SCHEMBL900119 0.74 ALOX15 (0.38) TP53ALOX15MEN1LMNAKMT2A
SCHEMBL27884492 0.73 ALOX15 (0.68) TP53ALOX15MEN1LMNAKMT2A
SCHEMBL28338818 0.73 ESR1 (0.36) ALOX15MEN1KMT2AHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3094325-B1 HETEROARYLS AND USES THEREOF TAKEDA PHARMACEUTICALS CO (JP) 2021-10-13 EP disclosed
EP-2501236-B1 N-[2-fluoro-3-(4-amino-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-phenyl]-4-benzenesulfonamide derivatives as Raf protein kinase modulators for the treatment of cancer PLEXXIKON INC (US) 2017-03-29 EP disclosed